Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12530/54356
Título : Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series
Autor : 
Filiación: Instituto de Investigación Sanitaria Gregorio Marañón
Palabras clave : 
Mesh: 
Fecha de publicación : 3-jun-2019
Editorial : BioMed Central
Citación : Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series
Resumen : Full RNA-Seq is a fundamental research tool for whole transcriptome analysis. However, it is too costly and time consuming to be used in routine clinical practice. We evaluated the transcript quantification agreement between RNA-Seq and a digital multiplexed gene expression platform, and the subtype call after running the PAM50 assay in a series of breast cancer patients classified as triple negative by IHC/FISH. The goal of this study is to analyze the concordance between both expression platforms overall, and for calling PAM50 triple negative breast cancer intrinsic subtypes in particular.
PMID: 31159741
URI : https://hdl.handle.net/20.500.12530/54356
Derechos: info:eu-repo/semantics/openAccess
ISSN : 1471-2164
Aparece en las colecciones: Hospitales > H. U. Gregorio Marañón > Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
s12864-019-5849-0.pdf1,83 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons